Original Research
Published on 27 Sep 2024
PXDN as a pan-cancer biomarker and promotes tumor progress via immune inhibition in nasopharyngeal carcinoma
in Head and Neck Cancer
- 4,110 views
- 4 citations
Original Research
Published on 27 Sep 2024
in Head and Neck Cancer
Original Research
Published on 23 Jan 2024
in Neuro-Oncology and Neurosurgical Oncology
Review
Published on 02 Apr 2012
in Genitourinary Oncology
Review
Published on 16 Mar 2022
in Parasite and Host
Original Research
Published on 16 Nov 2022
in Cancer Immunity and Immunotherapy
Review
Published on 04 Jan 2023
in Viral Immunology
Original Research
Published on 28 Jan 2020
in Comparative Immunology
Original Research
Published on 12 Aug 2025
in T Cell Biology
Original Research
Published on 30 Aug 2021
in Cancer Genetics and Oncogenomics
Review
Published on 03 Dec 2019
in T Cell Biology
Original Research
Published on 28 Oct 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 24 Feb 2022
in Head and Neck Cancer